Ropes & Gray has advised Bain Capital on the transaction. Kailera Therapeutics, a clinical-stage biopharmaceutical company specializing in obesity therapies, has announced the closing of a...
Kailera Therapeutics Raises $600 Million in Series B Financing
Curevo’s $110 Million Series B Financing Round
Ropes & Gray represented Sanofi Ventures in the transaction. Curevo Vaccine (Curevo) announced raising $110 million in Series B financing. Leading the round is new investor...
Enveda’s $150 Million Series C Financing Round
Ropes & Gray represented Sanofi in the transaction. Enveda announced it has raised $150 million in a Series C financing round, led by Sanofi Ventures. The...
Novartis’ $3.1 Billion Acquisition of Anthos Therapeutics
Goodwin Procter and Ropes & Gray represented Anthos Therapeutics in the transaction. Novartis announced its acquisition of Anthos Therapeutics, Inc. for up to $3.1 billion. Under...
Cullinan Oncology’s Collaboration with Taiho Pharmaceutical
Ropes & Gray represented Cullinan Oncology in the deal. Cullinan Oncology announced a strategic collaboration with Taiho Pharmaceutical under which Taiho will acquire Cullinan Oncology’s subsidiary Cullinan...
National Resilience’s $110 Million Alliance with Bluebird Bio to Develop Cell Therapies
Ropes & Gray advised National Resilience on the deal. National Resilience, Inc., a biopharmaceutical manufacturing specialist, closed a strategic alliance with bluebird bio, Inc., to accelerate...